Zhiying Ai
-
- MicroRNA in disease regulation 7
-
- Pluripotent Stem Cells Research 15
- CRISPR and Genetic Engineering 8
- Epigenetics and DNA Methylation 3
- Renal and related cancers 2
- RNA Interference and Gene Delivery 2
-
- Ferroptosis and cancer prognosis 2
-
- Vitamin C and Antioxidants Research 2
- Co-authors
- Zekun GuoYongyan WuYong ZhangXiaoyan ShiYong XiaXiao‐Long YangWenzhi ShenChanglin Li
- Journals
- PLoS ONE (3 papers)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Zhiying Ai
21 papers receiving 459 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 145
- Molecular Biology 328
- Pulmonary and Respiratory Medicine 118
- Developmental Neuroscience 12
- Genetics 25
Countries citing papers authored by Zhiying Ai
This map shows the geographic impact of Zhiying Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiying Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiying Ai more than expected).
Fields of papers citing papers by Zhiying Ai
This network shows the impact of papers produced by Zhiying Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiying Ai. The network helps show where Zhiying Ai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhiying Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 13 | |
| 7 | 2020 | 112 | |
| 8 | 2018 | 2 | |
| 9 | 2017 | 6 | |
| 10 | 2016 | 16 | |
| 11 | 2015 | 55 | |
| 12 | 2015 | 2 | |
| 13 | 2015 | 28 | |
| 14 | 2015 | 10 | |
| 15 | 2014 | 27 | |
| 16 | 2014 | 3 | |
| 17 | 2014 | 5 | |
| 18 | 2013 | 16 | |
| 19 | 2013 | 35 | |
| 20 | 2013 | 29 |
About Zhiying Ai
Zhiying Ai is a scholar working on Health Informatics, Cancer Research and Molecular Biology, having authored 23 papers that have together received 461 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (15 papers), CRISPR and Genetic Engineering (8 papers), MicroRNA in disease regulation (7 papers), Epigenetics and DNA Methylation (3 papers), Renal and related cancers (2 papers), RNA Interference and Gene Delivery (2 papers), Ferroptosis and cancer prognosis (2 papers) and Vitamin C and Antioxidants Research (2 papers). The work is most often cited by research in Cancer Research (145 citations), Molecular Biology (328 citations) and Pulmonary and Respiratory Medicine (118 citations). Zhiying Ai has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Zekun Guo, Yongyan Wu, Yong Zhang, Xiaoyan Shi, Yong Xia, Xiao‐Long Yang, Wenzhi Shen, Changlin Li, Haibo Wu and Juan Du. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.